Stromal organization as predictive biomarker for the treatment of colon cancer with adjuvant bevacizumab; a post-hoc analysis of the AVANT trial
暂无分享,去创建一个
H. Putter | R. Tollenaar | W. Mesker | H. Gelderblom | A. Kiialainen | C. Mancao | S. Zunder | Priscilla van der Wilk | Tim Dekker